Duration of progesterone-in-oil support after in vitro fertilization and embryo transfer: a randomized, controlled trial

被引:16
|
作者
Goudge, Christine S. [1 ]
Nagel, Theodore C. [1 ]
Damario, Mark A. [1 ]
机构
[1] Univ Minnesota, Div Reprod Endocrinol & Infertil, Dept Obstet Gynecol & Womens Hlth, Minneapolis, MN USA
关键词
Luteal phase support; progesterone-in-oil; in vitro fertilization; pregnancy outcome; LUTEAL-PHASE SUPPORT; INFERTILITY TREATMENT; SUPPLEMENTATION; METAANALYSIS; CYCLES;
D O I
10.1016/j.fertnstert.2009.05.003
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To determine the efficacy of a short P-in-oil protocol (11 days) in comparison with a traditional P-in-oil protocol (6 weeks) after IVF and embryo transfer. Design: Prospective randomized, controlled trial. Setting: Tertiary referral reproductive medicine unit. Patient(s): The first IVF-embryo transfer cycle of women <= 37 years old. Intervention(s): Either the standard protocol, 50 mg of IM P-in-oil daily for 6 weeks (group 1) or the study protocol, 50 mg of IM P-in-oil daily for 11 days (group 2). Main Outcome Measure(s): Clinical pregnancy, ongoing pregnancy, and live birth rates. Result(s): One hundred one patients were enrolled (48 in group 1, 53 in group 2). Mean age (31.8 years vs. 32.7 years) and reasons for infertility were not different between the groups. Despite higher embryo quality in group 1 than in group 2 (60.3 vs. 51.6), clinical (63.0% vs. 62.7%) and ongoing (58.7% vs. 51.0%) pregnancy rates (PR) were not significantly different. Live birth rates (52.2% vs. 49.0%) were not significantly different. Conclusion(s): Pregnancy and live birth rates were not different between the two groups, suggesting that the common practice of lengthy (>= 6 weeks) P support of IVF pregnancies may be unnecessary. (Fertil Steril (R) 2010; 94: 946-51. (c) 2010 by American Society for Reproductive Medicine.)
引用
收藏
页码:946 / 951
页数:6
相关论文
共 50 条
  • [21] Randomized Trial of Harp Therapy During In Vitro Fertilization-Embryo Transfer
    Murphy, Erin M.
    Nichols, Jennifer
    Somkuti, Steve G.
    Sobel, Michael
    Braverman, Andrea
    Barmat, Larry I.
    JOURNAL OF EVIDENCE-BASED INTEGRATIVE MEDICINE, 2014, 19 (02): : 93 - 98
  • [22] Intramuscular progesterone (Gestone) versus vaginal progesterone suppository (Cyclogest) for luteal phase support in cycles of in vitro fertilization–embryo transfer: patient preference and drug efficacy
    Amal Yaseen Zaman
    Serdar Coskun
    Ahmed Abdullah Alsanie
    Khalid Arab Awartani
    Fertility Research and Practice, 3 (1)
  • [23] Crinone 8%* vaginal progesterone gel results in lower embryonic implantation efficiency after in vitro fertilization-embryo transfer
    Damario, MA
    Goudas, VT
    Sesson, DR
    Hammitt, DG
    Dumesic, DA
    FERTILITY AND STERILITY, 1999, 72 (05) : 830 - 836
  • [24] Comparison of Vaginal Gel and Intramuscular Progesterone for In vitro Fertilization and Embryo Transfer with Gonadotropin-Releasing Hormone Antagonist Protocol
    Chi, Hong-Bin
    Liu, Na-Na
    Li, Rong
    Tao, Li-Yuan
    Chen, Li-Xue
    Qiao, Jie
    CHINESE MEDICAL JOURNAL, 2018, 131 (13) : 1557 - 1561
  • [25] Effect of 17α-hydroxyprogesterone caproate before embryo transfer on the outcome of in vitro fertilization and embryo transfer:: a randomized trial
    Abu-Musa, Antoine
    Usta, Ihab
    Nassar, Anwar
    Hajami, Fatiha
    Hannoun, Antoine
    FERTILITY AND STERILITY, 2008, 89 (05) : 1098 - 1102
  • [26] Comparing the outcomes of in-vitro fertilization in patients receiving vaginal, subcutaneous, and intramuscular progesterone for luteal phase support: a three-armed randomized controlled trial
    Tehraninejad, Ensieh Shahrokh
    Alizadeh, Sanaz
    Nekoo, Elham Azimi
    Zargarzadeh, Nikan
    Shariat, Mamak
    Haghollahi, Fedyeh
    Tarafdari, Azadeh
    Parsaei, Mohammadamin
    BMC WOMENS HEALTH, 2024, 24 (01)
  • [27] Effect of music therapy on the anxiety levels and pregnancy rate of women undergoing in vitro fertilization-embryo transfer: A randomized controlled trial
    Aba, Yilda Arzu
    Avci, Dilek
    Guzel, Yilmaz
    Ozcelik, Semanur Kumral
    Gurtekin, Basak
    APPLIED NURSING RESEARCH, 2017, 36 : 19 - 24
  • [28] Oral micronized progesterone versus vaginal progesterone for luteal phase support in fresh embryo transfer cycles: a multicenter, randomized, non-inferiority trial
    Niu, Yue
    Liu, Hong
    Li, Xiufang
    Zhao, Junli
    Hao, Guimin
    Sun, Yun
    Zhang, Bo
    Hu, Chunxiu
    Lu, Yingli
    Ren, Chun'e
    Yuan, Yingying
    Zhang, Jie
    Lu, Yao
    Wen, Qianqian
    Guo, Min
    Sui, Mingxing
    Wang, Guili
    Zhao, Dingying
    Chen, Zi-Jiang
    Wei, Daimin
    HUMAN REPRODUCTION, 2023, 38 : II24 - II33
  • [29] Oral, vaginal or intramuscular progesterone in programmed frozen embryo transfer cycles: a pilot randomized controlled trial
    Pabuccu, Emre
    Kovanci, Ertug
    Israfilova, Guler
    Tulek, Firat
    Demirel, Cem
    Pabuccu, Recai
    REPRODUCTIVE BIOMEDICINE ONLINE, 2022, 45 (06) : 1145 - 1151
  • [30] Vaginal micronized progesterone versus intramuscular progesterone for luteal support in women undergoing in vitro fertilization-embryo transfer
    Mitwally, Mohamed F.
    Diamond, Michael P.
    Abuzeid, Mostafa
    FERTILITY AND STERILITY, 2010, 93 (02) : 554 - 569